GlobeNewswire 8/7/2024 Ocular Therapeutix™ Reports Second Quarter 2024 Results
GlobeNewswire 8/7/2024 Ocular Therapeutix™ Announces FDA Feedback That SOL-R Trial is Appropriate as a Registrational Study...
GlobeNewswire 8/7/2024 EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corpora...
GlobeNewswire 8/6/2024 Celestica Announces Availability of the SC6100: A Next-Generation Storage Controller for Demanding E...
GlobeNewswire 8/5/2024 4DMT Advances Leadership in Large Market Ophthalmology with Senior Management Hires and Formation of...
GlobeNewswire 8/1/2024 Adverum Biotechnologies Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Gran...
GlobeNewswire 8/1/2024 Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results
TeleTrader 7/31/2024 Nvidia recovers from yesterday's slump, surges over 10%
TeleTrader 7/31/2024 AMD jumps over 10% on strong earnings
TeleTrader 7/30/2024 AMD's Q2 net income rose 881% to $265M
GlobeNewswire 7/30/2024 AMD Reports Second Quarter 2024 Financial Results
TeleTrader 7/30/2024 Wall Street closes mostly lower as tech stocks struggle
TeleTrader 7/30/2024 Nasdaq drops 1% as Nvidia sinks more than 6%
GlobeNewswire 7/30/2024 Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024
GlobeNewswire 7/30/2024 Ocular Therapeutix™ Announces First Patients Enrolled in Phase 3 SOL-R Wet AMD Study
TeleTrader 7/29/2024 Wall Street opens higher ahead of earnings-packed week
TeleTrader 7/29/2024 US up in premarket as tech earnings loom
GlobeNewswire 7/24/2024 YieldMax™ Launches Short NVDA Option Income Strategy ETF (DIPS)
GlobeNewswire 7/22/2024 AMD President Victor Peng to Retire
GlobeNewswire 7/22/2024 Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednes...
TeleTrader 7/22/2024 Samsung, ADM to collab in high-performance substrates
GlobeNewswire 7/18/2024 Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 7/18/2024 Alkeus Pharmaceuticals Announces Presentation of a TEASE-3 Study Update Showing Progression Stalled ...
TeleTrader 7/17/2024 Nasdaq 100 closes almost 3% lower as tech sell-off continues
TeleTrader 7/17/2024 US opens lower as investors dodge chip stocks